Retour
Fourchette du Jour
43,46 €
45,92 €
Fourchette 52 Semaines
22,71 €
49,82 €
Volume
1 267 776
Moyenne 50J / 200J
45,04 €
/
38,36 €
Clôture Précédente
44,64 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -13,3 | 0,4 |
| P/B | 20,4 | 2,9 |
| ROE % | -123,1 | 3,8 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
55,67 €
+27.5%
Low: 50,00 €
High: 60,00 €
BPA Prévisionnel
-3,14 €
CA Est.
20 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,34 €
0,51 € – 3,20 €
|
870 M | 4 |
| FY2029 |
-0,19 €
-0,44 € – -0,07 €
|
600 M | 4 |
| FY2028 |
-1,24 €
-2,16 € – -0,20 €
|
370 M | 10 |
Points Clés
Debt/Equity of 0,44 — conservative balance sheet
Negative free cash flow of -300,64M
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-123,08%
ROIC-81,40%
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
0,44
Current Ratio6,95
Interest Coverage-55,80
Valorisation
P/E Ratio
-13,27
P/B Ratio20,43
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -377,94M |
| ROE | -123,08% | ROA | -93,49% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -300,64M |
| ROIC | -81,40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 6,95 |
| Interest Coverage | -55,80 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -13,27 | P/B Ratio | 20,43 |
| P/S Ratio | N/A | PEG Ratio | -0,40 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,02B | Enterprise Value | 4,80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 33,19M | 18,82M |
| Net Income | -377,94M | -246,29M | -165,79M | -134,50M | -131,80M |
| EPS (Diluted) | -3,29 | -2,47 | -1,99 | -2,21 | -3,59 |
| Gross Profit | -1,66M | -1,94M | -2,84M | -89,85M | -89,65M |
| Operating Income | -384,65M | -252,05M | -171,30M | -134,37M | -129,92M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 404,27M | 474,92M | 311,04M | 358,17M | 304,45M |
| Total Liabilities | 158,78M | 106,29M | 85,82M | 97,93M | 132,37M |
| Shareholders' Equity | 245,49M | 368,63M | 225,22M | 260,24M | 172,07M |
| Total Debt | 108,92M | 65,13M | 61,82M | 69,40M | 84,47M |
| Cash & Equivalents | 323,53M | 177,88M | 101,86M | 103,28M | 212,84M |
| Current Assets | 385,15M | 451,17M | 288,19M | 328,02M | 265,32M |
| Current Liabilities | 55,42M | 46,94M | 32,74M | 36,39M | 64,30M |